600
Participants
Start Date
December 31, 2000
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
Radiotherapy 70 Gy
Radiotherapy to the prostate
Radiotherapy 76 Gy
Radiotherapy to the prostate
Androgen blockade
Duration : 6 months
Centre de Recherche Clinique du CHUS, Sherbrooke
Collaborators (1)
AstraZeneca
INDUSTRY
Abdenour Nabid
OTHER